| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/17/2001 | WO2000024755A9 Ovary-specific genes and proteins |
| 05/17/2001 | WO1999049882A3 Vegf and vegf-c as infant formula supplements |
| 05/17/2001 | WO1999048536A3 Delivery of long lasting therapeutic agents by forming covalent attachments in vivo |
| 05/17/2001 | WO1999044620A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/17/2001 | WO1994003601A3 Cloning, expression and uses for neurocan as a chondroitin sulfate proteoglycan |
| 05/17/2001 | US20010001309 For treating pathologies related to altered alpha v beta 3 integrin-mediated cell attachment, in particular wherein inhibition of angiogenesis is desired, for example in tumors, also associated with metastasis |
| 05/17/2001 | US20010001290 Methods for enhancing the production of viral vaccines in cell culture |
| 05/17/2001 | DE19954843A1 Verfahren zur Verkapselung von Proteinen oder Peptiden in Liposomen, mit dem Verfahren hergestellte Liposomen und deren Verwendung A process for the encapsulation of proteins or peptides in liposomes, liposomes produced by the method and the use thereof |
| 05/17/2001 | DE19953732A1 New human virus-inhibiting peptide, useful e.g. for treating viral or other infections or cancer, comprises fragment of alpha1-antitrypsin |
| 05/17/2001 | DE19953339A1 Secretinfragmente Secretinfragmente |
| 05/17/2001 | DE19952983A1 Verfahren zum Transfer von molekularen Substanzen mit prokaryontischen nukleinsäurebindenden Proteinen A method for the transfer of molecular substances with prokaryotic nucleic acid binding proteins |
| 05/17/2001 | DE19952957A1 Modulare Transportsysteme für molekulare Substanzen und deren Herstellung und Verwendung Modular Transport systems for molecular substances and their production and use |
| 05/17/2001 | DE10044129A1 New autogenous vaccine useful in the treatment of autoimmune and allergic diseases |
| 05/17/2001 | DE10035098A1 Composition for treating heart disease, e.g. hypertension, comprises peptide that mimics the alpha1 interaction domain or compound that increases myosin phosphorylation |
| 05/17/2001 | CA2404763A1 Mutated il-13 molecules and their uses |
| 05/17/2001 | CA2391448A1 Use of vasoactive intestinal peptides and kits therefor |
| 05/17/2001 | CA2391415A1 Methods of treating inflammatory bowel disease using cholera toxin b subunit |
| 05/17/2001 | CA2391369A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | CA2391278A1 Therapeutic compositions and methods of use thereof |
| 05/17/2001 | CA2391226A1 Reduced side-effect hemoglobin compositions |
| 05/17/2001 | CA2391129A1 Lentiviral vector transduction of hematopoietic stem cells |
| 05/17/2001 | CA2390995A1 Recombinant gelatin in vaccines |
| 05/17/2001 | CA2390854A1 Peptides for treatment of erectile dysfunction |
| 05/17/2001 | CA2390834A1 Transplant/implant device and method for its production |
| 05/17/2001 | CA2390655A1 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 05/17/2001 | CA2390650A1 Novel human proteases and polynucleotides encoding the same |
| 05/17/2001 | CA2390632A1 Methods of treating short stature disorders related to the short stature homeobox-containing (shox) gene |
| 05/17/2001 | CA2390510A1 Use of caspase-14 and caspase-14 modulators to diagnose and/or treat skin, eye and brain disorders |
| 05/17/2001 | CA2390438A1 19 human secreted proteins |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2390374A1 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | CA2390231A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 05/17/2001 | CA2389954A1 Method of inducing angiogenesis |
| 05/17/2001 | CA2389724A1 28 human secreted proteins |
| 05/17/2001 | CA2389722A1 15 human secreted proteins |
| 05/17/2001 | CA2389550A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/17/2001 | CA2389524A1 Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
| 05/17/2001 | CA2389506A1 Nucleic acid-containing complex |
| 05/17/2001 | CA2389392A1 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 05/17/2001 | CA2389330A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | CA2389326A1 35 human secreted proteins |
| 05/17/2001 | CA2389305A1 28 human secreted proteins |
| 05/17/2001 | CA2389176A1 A method and composition for treating prostate cancer |
| 05/17/2001 | CA2389041A1 Peptide analogs and mimetics suitable for in vivo use in the treatment of diseases associated with abnormal protein folding into amyloid, amyloid-like deposits or .beta.-sheet rich pathological precursor thereof |
| 05/17/2001 | CA2388918A1 Methods for administration of therapeutic agents on an antiangiogenic schedule |
| 05/17/2001 | CA2388914A1 15 human secreted proteins |
| 05/17/2001 | CA2388912A1 6 human secreted proteins |
| 05/17/2001 | CA2388644A1 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 05/17/2001 | CA2388643A1 Use of lytic toxins and toxin conjugates |
| 05/17/2001 | CA2388477A1 Recombinant gelatins with uniform molecular weight |
| 05/17/2001 | CA2388044A1 Hydroxyeicosatetraenoate salts, compositions and methods of use in treating dry eye disorders |
| 05/17/2001 | CA2388019A1 24 human secreted proteins |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387964A1 22 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/17/2001 | CA2387089A1 Interferon gamma for the treatment of asthma |
| 05/17/2001 | CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances |
| 05/16/2001 | EP1099708A1 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| 05/16/2001 | EP1099707A2 Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses |
| 05/16/2001 | EP1099700A1 Crystalline oxathiolane derivatives |
| 05/16/2001 | EP1099693A1 Radiolabelled peptide compounds |
| 05/16/2001 | EP1099446A2 Combination treatment for depression and anxiety containing a CNS-penetrant NK-1 receptor antagonist and an antidepressant or anxiolytic agent |
| 05/16/2001 | EP1099445A2 Treatment of neuromuscular disorders and conditions with different botulinum serotype |
| 05/16/2001 | EP1099443A1 Transplant/implant device and method for its production |
| 05/16/2001 | EP1099441A2 Compositions containing apo B secretion/MTP inhibitors and anti-obesity agents and use thereof |
| 05/16/2001 | EP1099439A2 Use of apo B secretion/MTP inhibitors |
| 05/16/2001 | EP1098985A1 Genes of the dead box protein family, their expression products and use |
| 05/16/2001 | EP1098981A1 A mutant human hepatitis b viral strain and uses thereof |
| 05/16/2001 | EP1098979A2 Fap alpha-specific antibody with improved producibility |
| 05/16/2001 | EP1098978A1 Gbs toxin receptor |
| 05/16/2001 | EP1098975A1 Orphan cytokine receptor |
| 05/16/2001 | EP1098974A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 05/16/2001 | EP1098971A2 Myotilin, an actin-organizing protein |
| 05/16/2001 | EP1098970A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 05/16/2001 | EP1098969A2 Use of nucleic acid molecules as antiviral agents |
| 05/16/2001 | EP1098968A2 Nitrilase homologs |
| 05/16/2001 | EP1098966A1 Methods for purifying nucleic acids |
| 05/16/2001 | EP1098962A2 Diacylglycerol acyl transferase proteins |
| 05/16/2001 | EP1098910A1 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders |
| 05/16/2001 | EP1098909A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 05/16/2001 | EP1098906A1 Peptide analogues of pacap |
| 05/16/2001 | EP1098905A2 Rna helicases modulating translation termination |
| 05/16/2001 | EP1098904A1 Axor10, a g-protein coupled receptor |
| 05/16/2001 | EP1098903A1 Novel method for preparing cyclosporin derivatives |
| 05/16/2001 | EP1098902A1 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
| 05/16/2001 | EP1098898A1 Calcium (3s) tetrahydro-3-furanyl(1s,2r)-3- (4-aminophenyl) sulfonyl] (isobutyl) amino] -1-benzyl-2- (phosphonooxy) propylcarbamate |
| 05/16/2001 | EP1098664A2 Conjugates for treating inflammatory disorders and associated tissue damage |
| 05/16/2001 | EP1098663A1 Slow release formulations comprising anionic polysaccharide |
| 05/16/2001 | EP1098661A2 Gnrh vaccines for suppressing reproductive behavior in animals |
| 05/16/2001 | EP1098660A1 Encapsulation of water soluble peptides |
| 05/16/2001 | EP1098659A2 Libraries of polyhydroxamates and their analogs |
| 05/16/2001 | EP1098658A1 Engineered proteins for analyte sensing |
| 05/16/2001 | EP1098654A1 Antilipemic composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | EP1098645A1 Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ards) and infant respiratory distress syndrome (irds) |
| 05/16/2001 | EP1098642A1 Methods for treating conditions modulated by lactosylceramide |
| 05/16/2001 | EP1098640A1 Anti-ulcer composition comprising a polysaccharide containing glucuronic acid |
| 05/16/2001 | EP1098635A1 Enteric coated pharmaceutical tablet and method of manufacturing |
| 05/16/2001 | EP1098628A1 Casein formulations for the delivery of bioactive constituents |
| 05/16/2001 | EP1039886A4 Hiv/fiv protease inhibitors having a small p3 residue |
| 05/16/2001 | EP1011328A4 Stimulation, modulation and/or inhibition of endothelial proteolytic activity and/or angiogenic activity |